Molecule is a pioneering company at the forefront of the Decentralized Science (DeSci) movement, where biotechnology and blockchain converge to democratize scientific research. With a mission to empower researchers and institutions globally, Molecule is known for its innovative projects such as VitaDAO, the first and largest biotech DAO, and the IP-NFT protocol, which brings intellectual property rights on-chain. The company has successfully raised over $20 million in funding to accelerate decentralized biotech innovation and is committed to reshaping the future of scientific discovery through blockchain technology.